XML 34 R47.htm IDEA: XBRL DOCUMENT

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2020

Earnings Per Share [Abstract]

Summary of net income (loss) attributable to Archrock common stockholders used in the calculation of basic and diluted income (loss) per common share

The following table shows net income (loss) used in the calculation of basic and diluted net income (loss) per common share (in thousands):


		Three Months Ended
		March 31,
		2020			2019
Income (loss) from continuing operations		$	(61,187)		$	19,729
Loss from discontinued operations, net of tax			—			(273)
Net income (loss)			(61,187)			19,456
Less: Net income attributable to participating securities			(322)			(356)
Net income (loss) attributable to common stockholders		$	(61,509)		$	19,100

Schedule of potential shares of common stock that were included in computing diluted income (loss) attributable to Archrock common stockholders per common share

The following table shows the potential shares of common stock that were included in computing diluted net income (loss) per common share (in thousands):


		Three Months Ended
		March 31,
		2020		2019
Weighted average common shares outstanding including participating securities		152,601		130,238
Less: Weighted average participating securities outstanding		(2,051)		(2,029)
Weighted average common shares outstanding used in basic net income (loss) per common share		150,550		128,209
Net dilutive potential common shares issuable:
On exercise of options and vesting of performance-based restricted stock units		—		40
On settlement of employee stock purchase plan shares		—		6
Weighted average common shares outstanding used in diluted net income (loss) per common share		150,550		128,255

Schedule of potential shares of common stock issuable, excluded from computation of diluted income (loss), attributable to Archrock common stockholders per common share

The following table shows the potential shares of common stock issuable that were excluded from computing diluted net income (loss) per common share as their inclusion would have been anti-dilutive (in thousands):


		Three Months Ended
		March 31,
		2020		2019
On exercise of options where exercise price is greater than average market value for the period		126		154
On exercise of options and vesting of performance-based restricted stock units		57		—
On settlement of employee stock purchase plan shares		29		—
Net dilutive potential common shares issuable		212		154